Demonstrates the connection between peripheral neuropathy and cognitive impairment in metabolic syndrome, suggesting new therapeutic approaches.
The metabolic syndrome, a state of progressive metabolic dysfunction, injures the peripheral and central nervous systems, promoting peripheral neuropathy (PN) and cognitive impairment (CI), respectively. We posit PN and CI are connected in the metabolic syndrome framework, built on the premise that neurons, whether in the peripheral or central nervous systems, are susceptible to similar injury from shared metabolic risk factors and pathophysiological processes. We highlight future studies for determining the relative evolution of PN and CI in metabolic syndrome, and propose revising the "stocking-glove" description of PN to "stocking-glove-hat" encompassing CI, concluding with research, therapeutic, and clinical implications. ANN NEUROL 2026.
No takes yet. Share an insight, caveat, or question.
Savelieff et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: